A German regenerative medicine institute near Frankfurt treating patients with their own bone marrow and fat-derived stem cells under an explicitly experimental framework.
The ANOVA Institute for Regenerative Medicine is a private clinic at Strahlenbergerstrasse 110 in Offenbach am Main, immediately east of Frankfurt in Germany. The site is published in German and English and gives a German telephone and fax number. It was founded by Dr mult. Michael K. Stehling, and the site also names Dr Johannes Atta and Dr rer. nat. Nicole Kühl.
What distinguishes ANOVA from many providers in this directory is that it treats only with autologous cells, meaning cells taken from the patient's own body. The site states explicitly that it does not use embryonic or foetal cells, allogeneic donor cells or umbilical cord cells, and gives reduced infection and immune rejection risk as its reason. Three preparations are described: bone marrow concentrate, harvested from the patient's bone marrow and containing the natural mix of cells found there, of which the site says roughly one per cent are mesenchymal stem cells; mesenchymal stem cells obtained from subcutaneous fat by a mini-liposuction and then cultured and expanded in the laboratory; and a cell-free preparation the site calls the stem cell secretome, described as the collected communication molecules secreted by mesenchymal stem cells.
The site says its stem cell products are inspected under good manufacturing practice with batch-by-batch quality control, and describes on-site diagnostic imaging including magnetic resonance and computed tomography scanning. It states that it works within a legally regulated framework in Germany.
The conditions listed span neurodegenerative disease including Parkinson's disease, motor neurone disease and multiple sclerosis; orthopaedic problems including osteoarthritis, knee degeneration and spinal conditions; autoimmune disease such as rheumatoid arthritis; and stroke, spinal cord injury, diabetes, chronic obstructive pulmonary disease and erectile dysfunction. The institute describes these treatments as experimental and individualised, drawn up by the treating physician for each patient, and sets out contraindications including active cancer, pregnancy, ventilator dependence and certain infections. Prices are not published on the pages read, although the site hosts an article discussing what stem cell therapy costs.
The site lists the following conditions, and describes the treatments it offers for them as experimental rather than established.
The site states that ANOVA treats only with autologous cells — cells taken from the patient's own body — and deliberately does not use donor, umbilical cord, foetal or embryonic cells.
The site names the following people in its overview pages.
The institute occupies premises at Strahlenbergerstrasse 110 in Offenbach am Main, close to Frankfurt. The site describes an on-site laboratory in which fat-derived mesenchymal stem cells are cultured and expanded, and says its stem cell products are inspected under good manufacturing practice with quality control applied batch by batch. It also describes diagnostic imaging on site, including magnetic resonance and computed tomography scanning. The site is available in German and English.
No prices are published on the overview pages read. The site hosts a separate article about the cost of stem cell therapy in general terms, but does not set out its own fees or a price range for any treatment.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.